$EXPO
EXPONENT INC

2015 Q1 Form 10-K Financial Statement

#000114420415012949 Filed on March 02, 2015

View on sec.gov

Income Statement

Concept 2015 Q1 2014 Q1 2014
Revenue $73.61M $72.80M $296.2M
YoY Change 1.11% 0.19% -0.01%
Cost Of Revenue $4.000M $3.700M $15.50M
YoY Change 8.11% 0.0% -3.73%
Gross Profit $69.60M $69.00M $289.2M
YoY Change 0.87% 0.0% 3.29%
Gross Profit Margin 94.55% 94.78% 97.65%
Selling, General & Admin $48.70M $50.20M $199.4M
YoY Change -2.99% -3.46% 0.3%
% of Gross Profit 69.97% 72.75% 68.95%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.400M $1.300M $5.400M
YoY Change 7.69% 18.18% 8.0%
% of Gross Profit 2.01% 1.88% 1.87%
Operating Expenses $55.50M $56.70M $240.2M
YoY Change -2.12% -8.27% 7.19%
Operating Profit $14.13M $12.30M $55.95M
YoY Change 14.9% 13.35% 0.08%
Interest Expense $0.00 $0.00 $2.400M
YoY Change -60.66%
% of Operating Profit 0.0% 0.0% 4.29%
Other Income/Expense, Net $1.700M $2.300M $7.872M
YoY Change -26.09% -13.34% 314.32%
Pretax Income $15.83M $14.70M $63.95M
YoY Change 7.67% 8.85% 0.07%
Income Tax $6.600M $5.900M $25.31M
% Of Pretax Income 41.7% 40.14% 39.57%
Net Earnings $9.243M $8.700M $38.64M
YoY Change 6.24% 9.08% 0.1%
Net Earnings / Revenue 12.56% 11.95% 13.05%
Basic Earnings Per Share $0.35 $1.42
Diluted Earnings Per Share $0.34 $155.9K $1.38
COMMON SHARES
Basic Shares Outstanding 26.59M shares 13.06M shares 27.23M shares
Diluted Shares Outstanding 27.32M shares 28.05M shares

Balance Sheet

Concept 2015 Q1 2014 Q1 2014
SHORT-TERM ASSETS
Cash & Short-Term Investments $154.4M $156.1M $154.4M
YoY Change -1.09% 40.63% -1.09%
Cash & Equivalents $129.5M $122.9M $45.50M
Short-Term Investments $24.90M $33.20M $24.90M
Other Short-Term Assets $14.70M $18.60M $14.70M
YoY Change -20.97% 24.0% -20.97%
Inventory
Prepaid Expenses
Receivables $86.37M $76.98M $86.40M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $266.5M $251.7M $255.5M
YoY Change 5.89% 21.82% 1.51%
LONG-TERM ASSETS
Property, Plant & Equipment $28.26M $28.72M $28.30M
YoY Change -1.59% 1.49% -1.39%
Goodwill $8.607M $8.607M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.121M $551.0K $72.90M
YoY Change 103.45% -98.93% 32.07%
Total Long-Term Assets $98.80M $92.48M $109.8M
YoY Change 6.83% 4.62% 18.7%
TOTAL ASSETS
Total Short-Term Assets $266.5M $251.7M $255.5M
Total Long-Term Assets $98.80M $92.48M $109.8M
Total Assets $365.3M $344.2M $365.3M
YoY Change 6.14% 16.67% 6.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.230M $2.798M $2.200M
YoY Change -20.3% -60.03% -21.43%
Accrued Expenses $6.705M $5.644M $68.90M
YoY Change 18.8% -81.43% 10.06%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $79.35M $72.15M $79.30M
YoY Change 9.98% 68.57% 9.99%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.862M $1.181M $41.70M
YoY Change 57.66% -96.53% 12.7%
Total Long-Term Liabilities $1.862M $1.181M $41.70M
YoY Change 57.66% -96.53% 12.7%
TOTAL LIABILITIES
Total Short-Term Liabilities $79.35M $72.15M $79.30M
Total Long-Term Liabilities $1.862M $1.181M $41.70M
Total Liabilities $121.0M $109.1M $121.0M
YoY Change 10.91% 41.88% 10.91%
SHAREHOLDERS EQUITY
Retained Earnings $247.0M $226.0M
YoY Change 9.26%
Common Stock $160.2M $141.3M
YoY Change 13.43%
Preferred Stock
YoY Change
Treasury Stock (at cost) $162.0M $132.4M
YoY Change 22.4%
Treasury Stock Shares 7.111M shares 3.363M shares
Shareholders Equity $244.3M $235.1M $244.3M
YoY Change
Total Liabilities & Shareholders Equity $365.3M $344.2M $365.3M
YoY Change 6.14% 16.67% 6.13%

Cashflow Statement

Concept 2015 Q1 2014 Q1 2014
OPERATING ACTIVITIES
Net Income $9.243M $8.700M $38.64M
YoY Change 6.24% 9.08% 0.1%
Depreciation, Depletion And Amortization $1.400M $1.300M $5.400M
YoY Change 7.69% 18.18% 8.0%
Cash From Operating Activities $22.20M $28.00M $48.30M
YoY Change -20.71% -638.46% -21.84%
INVESTING ACTIVITIES
Capital Expenditures -$1.000M -$1.600M $6.226M
YoY Change -37.5% -181.67% -200.42%
Acquisitions
YoY Change
Other Investing Activities $900.0K -$20.10M $7.400M
YoY Change -104.48% -279.46% -158.27%
Cash From Investing Activities -$200.0K -$21.70M $2.400M
YoY Change -99.08% -333.33% -112.7%
FINANCING ACTIVITIES
Cash Dividend Paid $7.927M
YoY Change
Common Stock Issuance & Retirement, Net $25.52M
YoY Change -207.68%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -7.500M -5.600M -43.10M
YoY Change 33.93% -63.16% 27.51%
NET CHANGE
Cash From Operating Activities 22.20M 28.00M 48.30M
Cash From Investing Activities -200.0K -21.70M 2.400M
Cash From Financing Activities -7.500M -5.600M -43.10M
Net Change In Cash 14.50M 700.0K 7.600M
YoY Change 1971.43% -106.31% -16.48%
FREE CASH FLOW
Cash From Operating Activities $22.20M $28.00M $48.30M
Capital Expenditures -$1.000M -$1.600M $6.226M
Free Cash Flow $23.20M $29.60M $42.07M
YoY Change -21.62% -513.47% -38.13%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015 us-gaap Rental Income Nonoperating
RentalIncomeNonoperating
2003000 USD
CY2014 us-gaap Reimbursement Revenue
ReimbursementRevenue
16125000 USD
CY2012 us-gaap Reimbursement Revenue
ReimbursementRevenue
26091000 USD
CY2015 us-gaap Labor And Related Expense
LaborAndRelatedExpense
183533000 USD
CY2014 us-gaap Labor And Related Expense
LaborAndRelatedExpense
184084000 USD
CY2015Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
45478000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
37099000 USD
CY2015Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
114239000 USD
CY2014Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
108249000 USD
CY2015Q1 expo Deferred Compensation Plan Liabilities Fair Value Disclosure
DeferredCompensationPlanLiabilitiesFairValueDisclosure
45394000 USD
CY2014Q1 expo Deferred Compensation Plan Liabilities Fair Value Disclosure
DeferredCompensationPlanLiabilitiesFairValueDisclosure
37926000 USD
CY2015Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
45394000 USD
CY2014Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
37926000 USD
CY2015Q1 expo Available For Sale Securities Short Term Investments Amortized Cost Due In Year One
AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCostDueInYearOne
20719000 USD
CY2015Q1 expo Available For Sale Securities Short Term Investments Amortized Cost Due In Year Two
AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCostDueInYearTwo
4171000 USD
CY2015Q1 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
24890000 USD
CY2015Q1 expo Available For Sale Securities Short Term Investments Estimated Fair Value Due In Year One
AvailableForSaleSecuritiesShortTermInvestmentsEstimatedFairValueDueInYearOne
20741000 USD
CY2015Q1 expo Available For Sale Securities Short Term Investments Estimated Fair Value Due In Year Two
AvailableForSaleSecuritiesShortTermInvestmentsEstimatedFairValueDueInYearTwo
4172000 USD
CY2015Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3386000 USD
CY2014Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2771000 USD
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2015Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16427000 shares
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16427000 shares
CY2015Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
3556000 shares
CY2014Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
3363000 shares
CY2015 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13455000 shares
CY2014 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13616000 shares
CY2012 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13780000 shares
CY2015 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13833000 shares
CY2014 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14025000 shares
CY2015 us-gaap Income Taxes Paid
IncomeTaxesPaid
27421000 USD
CY2014 us-gaap Income Taxes Paid
IncomeTaxesPaid
24701000 USD
CY2012 us-gaap Income Taxes Paid
IncomeTaxesPaid
24104000 USD
CY2015 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
4000 USD
CY2014 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-14000 USD
CY2012 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-28000 USD
CY2015 expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
6008000 USD
CY2014 expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
5807000 USD
CY2012 expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
5343000 USD
CY2015 us-gaap Revenues
Revenues
304704000 USD
CY2014 us-gaap Revenues
Revenues
296168000 USD
CY2012 us-gaap Revenues
Revenues
292653000 USD
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
63549000 USD
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
55946000 USD
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
57620000 USD
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4947000 USD
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6226000 USD
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4942000 USD
CY2015 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5404000 USD
CY2014 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4951000 USD
CY2012 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4711000 USD
CY2015 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
289209000 USD
CY2014 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
280043000 USD
CY2012 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
266562000 USD
CY2015 us-gaap Reimbursement Revenue
ReimbursementRevenue
15495000 USD
CY2014 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
800000 USD
CY2012 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-310000 USD
CY2015 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1718000 USD
CY2014 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1705000 USD
CY2012 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1763000 USD
CY2015 us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
15495000 USD
CY2014 us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
16125000 USD
CY2012 us-gaap Labor And Related Expense
LaborAndRelatedExpense
171809000 USD
CY2015 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
26285000 USD
CY2014 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
25299000 USD
CY2012 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
23574000 USD
CY2012 us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
26091000 USD
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15842000 USD
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14714000 USD
CY2012 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13559000 USD
CY2015 us-gaap Operating Expenses
OperatingExpenses
241155000 USD
CY2014 us-gaap Operating Expenses
OperatingExpenses
240222000 USD
CY2012 us-gaap Operating Expenses
OperatingExpenses
235033000 USD
CY2015 us-gaap Investment Income Net
InvestmentIncomeNet
150000 USD
CY2014 us-gaap Investment Income Net
InvestmentIncomeNet
127000 USD
CY2012 us-gaap Investment Income Net
InvestmentIncomeNet
328000 USD
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4266000 USD
CY2014 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7872000 USD
CY2012 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3801000 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
67965000 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
63945000 USD
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
61749000 USD
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27264000 USD
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
25305000 USD
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24524000 USD
CY2015 us-gaap Net Income Loss
NetIncomeLoss
40701000 USD
CY2014 us-gaap Net Income Loss
NetIncomeLoss
38640000 USD
CY2012 us-gaap Net Income Loss
NetIncomeLoss
37225000 USD
CY2015 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.02
CY2014 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.84
CY2012 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.70
CY2015 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.94
CY2014 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.76
CY2012 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.60
CY2015 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.00
CY2014 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.60
CY2012 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
CY2015 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2014 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2012 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2015 us-gaap Goodwill Other Changes
GoodwillOtherChanges
0 USD
CY2014 us-gaap Goodwill Other Changes
GoodwillOtherChanges
0 USD
CY2012 us-gaap Goodwill Other Changes
GoodwillOtherChanges
0 USD
CY2015 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1017000 USD
CY2014 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
373000 USD
CY2012 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
249000 USD
CY2015 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
39688000 USD
CY2014 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
38999000 USD
CY2012 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
37446000 USD
CY2015 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-885000 USD
CY2014 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-340000 USD
CY2012 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-560000 USD
CY2015 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-273000 USD
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
13079000 USD
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
13168000 USD
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
12378000 USD
CY2015 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-6077000 USD
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3398000 USD
CY2012 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4194000 USD
CY2015 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
5100000 USD
CY2014 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
4267000 USD
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1455000 USD
CY2012 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
14059000 USD
CY2014 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
106000 USD
CY2012 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
717000 USD
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
48252000 USD
CY2012 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
3948000 USD
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
11106000 USD
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-6676000 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
61792000 USD
CY2012 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
48505000 USD
CY2015 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
5260000 USD
CY2014 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
33422000 USD
CY2012 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
515000 USD
CY2015 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
11642000 USD
CY2014 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3002000 USD
CY2012 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
7374000 USD
CY2015 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
6744000 USD
CY2014 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
4665000 USD
CY2012 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
9667000 USD
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5320000 USD
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4596000 USD
CY2012 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3379000 USD
CY2015 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
6142000 USD
CY2014 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
19190000 USD
CY2012 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
3770000 USD
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
2435000 USD
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-18880000 USD
CY2012 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1169000 USD
CY2015 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
5100000 USD
CY2014 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
4267000 USD
CY2012 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
3948000 USD
CY2015 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
6356000 USD
CY2014 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
6402000 USD
CY2012 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3531000 USD
CY2015 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
30921000 USD
CY2014 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
25519000 USD
CY2012 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
22887000 USD
CY2015 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
2107000 USD
CY2014 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1812000 USD
CY2012 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
3611000 USD
CY2015 us-gaap Payments Of Dividends
PaymentsOfDividends
13058000 USD
CY2014 us-gaap Payments Of Dividends
PaymentsOfDividends
7927000 USD
CY2012 us-gaap Payments Of Dividends
PaymentsOfDividends
0 USD
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-43128000 USD
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-33769000 USD
CY2012 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-18859000 USD
CY2015 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1017000 USD
CY2014 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
537000 USD
CY2012 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
352000 USD
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
6542000 USD
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
9680000 USD
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
28829000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
113268000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
84439000 USD
CY2015 dei Document Type
DocumentType
10-K
CY2015 dei Amendment Flag
AmendmentFlag
false
CY2015 dei Document Period End Date
DocumentPeriodEndDate
2015-01-02
CY2015 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2015 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2015 dei Entity Registrant Name
EntityRegistrantName
EXPONENT INC
CY2015 dei Entity Central Index Key
EntityCentralIndexKey
0000851520
CY2015 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-02
CY2015 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2015 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2015 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2015 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2012 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
23395000 USD
CY2012 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
518000 USD
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
186715000 USD
CY2015 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1147000 USD
CY2014 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1166000 USD
CY2012 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1008000 USD
CY2014Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
960000 USD
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
294000 USD
CY2012 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2607000 USD
CY2015 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
5100000 USD
CY2014Q3 dei Entity Public Float
EntityPublicFloat
837777802 USD
CY2015 dei Trading Symbol
TradingSymbol
EXPO
CY2015Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12870974 shares
CY2015 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-304000 USD
CY2014 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
187000 USD
CY2012 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
184000 USD
CY2015 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
3000 USD
CY2014 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-10000 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
4267000 USD
CY2012 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
3948000 USD
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6792000 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7107000 USD
CY2012 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-19000 USD
CY2015Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
1000000 USD
CY2014 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
1578000 USD
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6289000 USD
CY2015 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
30921000 USD
CY2014 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
25011000 USD
CY2015 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
6008000 USD
CY2014 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
5807000 USD
CY2012 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
5343000 USD
CY2015 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-6356000 USD
CY2014 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-6028000 USD
CY2012 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-3532000 USD
CY2015 expo Dividends And Dividend Equivalent Payments Declared
DividendsAndDividendEquivalentPaymentsDeclared
13189000 USD
CY2014 expo Dividends And Dividend Equivalent Payments Declared
DividendsAndDividendEquivalentPaymentsDeclared
7971000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
216429000 USD
CY2015 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times, serif; font-size-adjust: none; font-stretch: normal" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: bold 10pt Times New Roman, serif; font-size-adjust: none; font-stretch: normal" align="justify"><font style="COLOR: rgb(0,0,0)">Use of Estimates</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, serif; font-size-adjust: none; font-stretch: normal" align="justify"><font style="COLOR: rgb(0,0,0)">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015 us-gaap Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, serif; font-size-adjust: none; font-stretch: normal" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: bold 10pt Times New Roman, serif; font-size-adjust: none; font-stretch: normal" align="justify"><font style="COLOR: rgb(0,0,0)">Deferred Revenues</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, serif; font-size-adjust: none; font-stretch: normal" align="justify"><font style="COLOR: rgb(0,0,0)">Deferred revenues represent amounts billed to clients in advance of services provided, primarily on fixed-price projects.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015 expo Defined Contribution Plan Employer Contribution Percentage Of Eligible Wages
DefinedContributionPlanEmployerContributionPercentageOfEligibleWages
0.07 pure
CY2015 expo Defined Contribution Plan Employer Contribution Annual Vesting Percentage
DefinedContributionPlanEmployerContributionAnnualVestingPercentage
0.2 pure
CY2015 expo Defined Contribution Plan Employer Contribution Annual Vesting Period
DefinedContributionPlanEmployerContributionAnnualVestingPeriod
P5Y
CY2015 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
6954000 USD
CY2014 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
6564000 USD
CY2012 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
6573000 USD
CY2006Q2 expo Authorized Common Stock Shares Limits On Use
AuthorizedCommonStockSharesLimitsOnUse
40000000 shares
CY2006Q2 expo Authorized Preferred Stock Shares Limits On Use
AuthorizedPreferredStockSharesLimitsOnUse
2000000 shares
CY2015 expo Gross Revenues
GrossRevenues
313723000 USD
CY2014 expo Gross Revenues
GrossRevenues
302742000 USD
CY2012 expo Gross Revenues
GrossRevenues
298818000 USD
CY2015 expo Sub Contractor Fees
SubContractorFees
9019000 USD
CY2014 expo Sub Contractor Fees
SubContractorFees
6574000 USD
CY2012 expo Sub Contractor Fees
SubContractorFees
6165000 USD
CY2015 expo Recovery Of Out Of Pocket Expenses
RecoveryOfOutOfPocketExpenses
5862000 USD
CY2014 expo Recovery Of Out Of Pocket Expenses
RecoveryOfOutOfPocketExpenses
6619000 USD
CY2012 expo Recovery Of Out Of Pocket Expenses
RecoveryOfOutOfPocketExpenses
6426000 USD
CY2015 us-gaap Recovery Of Direct Costs
RecoveryOfDirectCosts
9633000 USD
CY2014 us-gaap Recovery Of Direct Costs
RecoveryOfDirectCosts
9506000 USD
CY2012 us-gaap Recovery Of Direct Costs
RecoveryOfDirectCosts
19665000 USD
CY2015 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
0 USD
CY2014 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
0 USD
CY2012 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
508000 USD
CY2015Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
154380000 USD
CY2014Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
156103000 USD
CY2015Q1 expo Cash Cash Equivalents And Short Term Investments Fair Value Disclosure
CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure
154403000 USD
CY2014Q1 expo Cash Cash Equivalents And Short Term Investments Fair Value Disclosure
CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure
156119000 USD
CY2014 us-gaap Rental Income Nonoperating
RentalIncomeNonoperating
1913000 USD
CY2012 us-gaap Rental Income Nonoperating
RentalIncomeNonoperating
1671000 USD
CY2015 expo Gain Loss On Deferred Compensation Investments
GainLossOnDeferredCompensationInvestments
2525000 USD
CY2014 expo Gain Loss On Deferred Compensation Investments
GainLossOnDeferredCompensationInvestments
6044000 USD
CY2012 expo Gain Loss On Deferred Compensation Investments
GainLossOnDeferredCompensationInvestments
2158000 USD
CY2015 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-293000 USD
CY2014 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-89000 USD
CY2012 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-61000 USD
CY2015 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
31000 USD
CY2014 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
4000 USD
CY2012 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
33000 USD
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4266000 USD
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
7872000 USD
CY2012 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3801000 USD
CY2015Q1 us-gaap Land
Land
4450000 USD
CY2014Q1 us-gaap Land
Land
4450000 USD
CY2015Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
35570000 USD
CY2014Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
34928000 USD
CY2015Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
12000 USD
CY2014Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
51000 USD
CY2015Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
35131000 USD
CY2014Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
32046000 USD
CY2015Q1 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
7714000 USD
CY2014Q1 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
7542000 USD
CY2015Q1 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
13169000 USD
CY2014Q1 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
12745000 USD
CY2015Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
96046000 USD
CY2014Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
91762000 USD
CY2015Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
67782000 USD
CY2014Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
63041000 USD
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
22500 shares
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
CY2015 expo Share Based Compensation Arrangement By Share Based Payment Award Options Exercise In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExerciseInPeriod
42000 shares
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
197500 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
217000 shares
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
195507 shares
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
134375 shares
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
70.80
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
22.86
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
38.43
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
32.06
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
38.22
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
30.35
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y10M6D
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y9M29D
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y9M29D
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
8426000 USD
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
8382000 USD
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
6819000 USD
CY2014Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
72967000 USD
CY2013Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
71919000 USD
CY2014Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
72331000 USD
CY2013Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
70096000 USD
CY2013Q1 us-gaap Revenues
Revenues
72660000 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
15160000 USD
CY2014Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
19238000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
12342000 USD
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
14133000 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
15365000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
18271000 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
18398000 USD
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13598000 shares
CY2014Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.80
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.63
CY2014Q4 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
74264000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
69036000 USD
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.68
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13537000 shares
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13637000 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13520000 shares
CY2015Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
69647000 USD
CY2013Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
68992000 USD
CY2014Q2 us-gaap Revenues
Revenues
75962000 USD
CY2013Q2 us-gaap Revenues
Revenues
75505000 USD
CY2014Q3 us-gaap Revenues
Revenues
76574000 USD
CY2013Q3 us-gaap Revenues
Revenues
75231000 USD
CY2014Q4 us-gaap Revenues
Revenues
78557000 USD
us-gaap Revenues
Revenues
72772000 USD
CY2015Q1 us-gaap Revenues
Revenues
73611000 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
14094000 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
17593000 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
16084000 USD
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
10851000 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
17515000 USD
CY2014Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
18375000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
14654000 USD
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
15827000 USD
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
13505000 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
9154000 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
10848000 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
11264000 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
11094000 USD
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
11040000 USD
us-gaap Net Income Loss
NetIncomeLoss
8722000 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
9243000 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
7976000 USD
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.68
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.80
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.83
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.82
CY2014Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.82
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.64
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.70
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.58
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.66
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.77
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.81
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.79
CY2014Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13469000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13556000 shares
CY2015Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13293000 shares
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13667000 shares
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13940000 shares
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14007000 shares
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13873000 shares
CY2014Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13824000 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
18.78
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
19.51
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1975000 USD
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
3177000 USD
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
7484000 USD
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13993000 shares
CY2013Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1998000 USD
CY2014Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3270000 USD
CY2013Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1945000 USD
CY2014Q4 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3262000 USD
CY2012 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
394000 USD
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
24.47
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1965000 USD
CY2015Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3216000 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13949000 shares
CY2015Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13659000 shares
CY2013Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14125000 shares
CY2015 us-gaap Other Labor Related Expenses
OtherLaborRelatedExpenses
12578000 USD
CY2014 us-gaap Other Labor Related Expenses
OtherLaborRelatedExpenses
12757000 USD
CY2012 us-gaap Other Labor Related Expenses
OtherLaborRelatedExpenses
11984000 USD
CY2015 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
501000 USD
CY2014 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
411000 USD
CY2015Q1 us-gaap Purchase Obligation
PurchaseObligation
320000 USD
CY2014Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.25
CY2013Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.15
CY2014Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.25
CY2013Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.15
CY2014Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.25
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.15
CY2015Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.25
CY2013Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.15
CY2015 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
13010000 USD
CY2014Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3262000 USD
CY2014 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
7877000 USD
CY2013Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1969000 USD
CY2014Q1 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
4478000 USD
CY2015Q1 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
2362000 USD
CY2014Q1 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
2106000 USD
CY2015Q1 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
7648000 USD
CY2006Q2 expo Preferred Stock Shares Authorized Limitation On Use
PreferredStockSharesAuthorizedLimitationOnUse
2000000 shares
CY2015Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2015Q1 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2015-03-27
CY2015Q1 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2015-03-06
CY2015Q1 us-gaap Dividends Payable Date Declared Day Month And Year
DividendsPayableDateDeclaredDayMonthAndYear
2015-02-04
CY2015Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
35078000 USD
CY2015 us-gaap Treasury Stock Reissued At Lower Than Repurchase Price
TreasuryStockReissuedAtLowerThanRepurchasePrice
6050000 USD
CY2014 us-gaap Treasury Stock Reissued At Lower Than Repurchase Price
TreasuryStockReissuedAtLowerThanRepurchasePrice
10383000 USD
CY2012 us-gaap Treasury Stock Reissued At Lower Than Repurchase Price
TreasuryStockReissuedAtLowerThanRepurchasePrice
10600000 USD
CY2015 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
425000 shares
CY2014 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
438000 shares
CY2012 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
480000 shares
CY2015Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2230000 USD
CY2014Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2798000 USD
CY2015Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6705000 USD
CY2014Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5644000 USD
CY2015Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
37010000 USD
CY2014Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
35370000 USD
CY2015Q1 us-gaap Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Current
PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent
6887000 USD
CY2014Q1 us-gaap Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Current
PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent
6976000 USD
CY2015Q1 us-gaap Accrued Vacation Current
AccruedVacationCurrent
8277000 USD
CY2014Q1 us-gaap Accrued Vacation Current
AccruedVacationCurrent
8004000 USD
CY2012Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
35000000 USD
CY2013Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
35000000 USD
CY2014Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
35000000 USD
CY2015 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
26647000 USD
CY2014 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
22468000 USD
CY2012 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
23562000 USD
CY2015 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
896000 USD
CY2014 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
1411000 USD
CY2012 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
852000 USD
CY2015 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
5798000 USD
CY2014 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
4824000 USD
CY2012 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
4304000 USD
CY2015 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
33341000 USD
CY2014 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
28703000 USD
CY2012 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
28718000 USD
CY2015 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-5059000 USD
CY2014 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-2703000 USD
CY2012 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-3378000 USD
CY2015 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-1018000 USD
CY2014 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-695000 USD
CY2012 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-816000 USD
CY2015Q1 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
7612000 USD
CY2015Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
5889000 USD
CY2015Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
3802000 USD
CY2015Q1 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
2173000 USD
CY2015Q1 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1069000 USD
CY2015 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
23788000 USD
CY2014 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
22381000 USD
CY2015Q1 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
2107000 USD
CY2015Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
22652000 USD
CY2015Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
459000 USD
CY2014Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
622000 USD
CY2015Q1 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
3377000 USD
CY2014Q1 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
3215000 USD
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.401 pure
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.396 pure
CY2012 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.397 pure
CY2014Q1 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
2925000 USD
CY2012 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
21612000 USD
CY2015 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
3226000 USD
CY2014 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
2819000 USD
CY2012 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
2409000 USD
CY2015 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
44000 USD
CY2014 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
36000 USD
CY2012 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
104000 USD
CY2015 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
289000 USD
CY2014 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
226000 USD
CY2012 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
296000 USD
CY2015 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
0 USD
CY2014 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-79000 USD
CY2012 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-40000 USD
CY2015 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
5000 USD
CY2014 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-6000 USD
CY2012 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
351000 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
4157000 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
6007000 USD
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2015 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
5100000 USD
CY2014 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
4267000 USD
CY2012 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
3948000 USD
CY2015Q1 us-gaap Deferred Tax Liabilities Undistributed Foreign Earnings
DeferredTaxLiabilitiesUndistributedForeignEarnings
3920000 USD
CY2015Q1 us-gaap Deferred Tax Liability Not Recognized Amount Of Unrecognized Deferred Tax Liability Undistributed Earnings Of Foreign Subsidiaries
DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries
313000 USD
CY2015Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
17244000 USD
CY2014Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
15539000 USD
CY2015Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
26873000 USD
CY2014Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
22373000 USD
CY2015Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther
28000 USD
CY2014Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther
0 USD
CY2015Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
44145000 USD
CY2014Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
37912000 USD
CY2015Q1 expo Deferred Tax Liabilities State Taxes
DeferredTaxLiabilitiesStateTaxes
1717000 USD
CY2014Q1 expo Deferred Tax Liabilities State Taxes
DeferredTaxLiabilitiesStateTaxes
1519000 USD
CY2015Q1 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
2978000 USD
CY2015Q1 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
0 USD
CY2014Q1 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
394000 USD
CY2015Q1 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
8531000 USD
CY2014Q1 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
8675000 USD
CY2015Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
35614000 USD
CY2014Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
29237000 USD
CY2012Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
908000 USD
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
486000 USD
CY2014 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
316000 USD
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
0 USD
CY2014 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
0 USD
CY2015 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
87000 USD
CY2014 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
77000 USD
CY2015 expo Unrecognized Tax Benefits Reductions Resulting From Change In Accounting Method
UnrecognizedTaxBenefitsReductionsResultingFromChangeInAccountingMethod
0 USD
CY2014 expo Unrecognized Tax Benefits Reductions Resulting From Change In Accounting Method
UnrecognizedTaxBenefitsReductionsResultingFromChangeInAccountingMethod
0 USD
CY2015 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
0 USD
CY2014 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
0 USD
CY2015Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1546000 USD
CY2015Q1 expo Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
27000 USD
CY2014Q1 expo Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
25000 USD
CY2015Q1 expo Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
4000 USD
CY2014Q1 expo Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
9000 USD
CY2015 expo Income Tax Benefit Associated With Stockbased Compensation
IncomeTaxBenefitAssociatedWithStockbasedCompensation
5141000 USD
CY2014 expo Income Tax Benefit Associated With Stockbased Compensation
IncomeTaxBenefitAssociatedWithStockbasedCompensation
5195000 USD
CY2012 expo Income Tax Benefit Associated With Stockbased Compensation
IncomeTaxBenefitAssociatedWithStockbasedCompensation
4844000 USD

Files In Submission

Name View Source Status
0001144204-15-012949-index-headers.html Edgar Link pending
0001144204-15-012949-index.html Edgar Link pending
0001144204-15-012949.txt Edgar Link pending
0001144204-15-012949-xbrl.zip Edgar Link pending
expo-20150102.xml Edgar Link completed
expo-20150102.xsd Edgar Link pending
expo-20150102_cal.xml Edgar Link unprocessable
expo-20150102_def.xml Edgar Link unprocessable
expo-20150102_lab.xml Edgar Link unprocessable
expo-20150102_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tchart.jpg Edgar Link pending
v401822_10k.htm Edgar Link pending
v401822_ex21-1.htm Edgar Link pending
v401822_ex23-1.htm Edgar Link pending
v401822_ex31-1.htm Edgar Link pending
v401822_ex31-2.htm Edgar Link pending
v401822_ex32-1.htm Edgar Link pending
v401822_ex32-2.htm Edgar Link pending